• Leave Your Message
    Products Categories
    Featured Products

    Oclacitinib Maleat CAS No.1208319-27-0 Pharmaceutical Intermediates

    Product name

    Oclacitinib Maleat

    CAS No.

    1208319-27-0

    EINECS  

    200-001-8

    Formula

    C19H27N5O6S

    Molecular Weight

    453.51

    Appearance

    White powder

    Purity

    ≥98%

    Type

    Pharmaceutical Intermediates

     - High Purity: Oclacitinib maleate has exceptional purity, ensuring reliable performance in pharmaceutical applications.

     - Integrated Manufacturing and Trading: Our company combines production and trading capabilities to provide customers with a seamless supply chain.

     - Selective JAK Inhibitor: This compound is a potent and selective inhibitor of Janus kinase (JAK), making it an effective tool for the treatment of allergic and inflammatory diseases.

     - Pharmaceutical Grade: Meets international quality standards to ensure safety and effectiveness.

     - Global Distribution: We provide competitive prices and prompt delivery to our customers worldwide.

     - Chemical Manufacturing Expertise: Our team has extensive knowledge in chemical production, particularly for pharmaceutical applications.

      Product details

      CAS No
      02

      introduce

       Oclacitinib maleate is a novel small molecule that acts as a selective inhibitor of Janus kinases (JAKs), a class of enzymes that play a crucial role in the signaling pathways of various cytokines associated with immune responses and inflammation. This compound is primarily used to treat allergic diseases such as atopic dermatitis in dogs and is currently being studied for its potential to treat other inflammatory diseases in veterinary and human medicine. By inhibiting JAKs, oclacitinib maleate is effective in modulating immune responses and alleviating symptoms associated with allergic reactions and chronic inflammation.

      125971~1
      02

      Physical and chemical properties

      - Molecular formula: C19H27N5O6S

       - Molecular weight: 453.51 g/mol

      - Molecular formula: C19H27N5O6S

       - Appearance: The compound is usually white powder.

       - Solubility: Oclacitinib maleate is soluble in organic solvents such as dimethyl sulfoxide (DMSO) and methanol, and has limited solubility in water, which facilitates various formulation processes.

       - Melting Point: The melting point of oclacitinib maleate is approximately 150-155°C, indicating that it is stable under standard laboratory conditions.

       - Chemical Stability: The compound exhibits good stability under recommended storage conditions, ensuring its effectiveness in pharmaceutical formulations.

      advantage

      -Selective JAK Inhibition: By specifically targeting the JAK enzyme, oclacitinib maleate offers a focused approach to treating allergies and inflammation, minimizing off-target effects.

      - Efficacy against allergies: Clinical studies have demonstrated that this compound is effective in alleviating the symptoms of atopic dermatitis and other allergies, making it a promising candidate for both veterinary and human applications.

      -Quality Assurance: Oclacitinib maleate is produced under strict quality control measures in compliance with international pharmaceutical standards to ensure safety and efficacy.

      - Cost Effective: Our integrated manufacturing and trading model enables us to offer competitive prices without compromising quality.

      - Global Availability: With a strong distribution network, we ensure timely delivery of Oclacitinib Maleate to customers around the world.

      Uses in the pharmaceutical industry

      In conclusion, oclacitinib maleate is an important compound with significant applications in the pharmaceutical industry. Its unique properties, coupled with our commitment to quality and reliability, make it an ideal choice for pharmaceutical manufacturers and researchers. By choosing oclacitinib maleate, you invest in a versatile compound that can drive innovation in allergy and inflammation treatments.